Search for Companies, Tipsters or Sources…
Companies
Tipsters
Brokers
Sources
Or view the latest share tips
Company Results
Tipster results
Broker results
Sources results
Tips from these results
Recent Share tips:
- Buy Seed Innovations Limited (SEED) by Hot Stock Rockets in ShareProphets
- Buy Coral Products (CRU) by Hot Stock Rockets in ShareProphets
- Avoid Cake Box Holdings (CBOX) by Steve Moore in ShareProphets
- Buy Taylor Wimpey (TW.) by Manika Premsingh in The Motley Fool
- Buy Legal & General Group (LGEN) by Manika Premsingh in The Motley Fool
- Buy Glencore (GLEN) by Manika Premsingh in The Motley Fool
- Buy Tesco (TSCO) by Manika Premsingh in The Motley Fool
- Buy BP (BP.) by Manika Premsingh in The Motley Fool
- Buy Lloyds Banking Group (LLOY) by Manika Premsingh in The Motley Fool
- Watch Clipper Logistics (CLG) by Royston Wild in The Motley Fool
- Watch Direct Line Insurance Group (DLG) by Royston Wild in The Motley Fool
- Avoid International Consolidated Airlines Group SA (CDI) (IAG) by Alan Oscroft in The Motley Fool
- Sell AO World (AO.) by Edmond Jackson in Interactive Investor
- Buy CMC Markets (CMCX) by Jon Smith in The Motley Fool
- Buy IG Group Holdings (IGG) by Jon Smith in The Motley Fool
- Buy Imperial Brands (IMB) by Jon Smith in The Motley Fool
- Buy British American Tobacco (BATS) by Jon Smith in The Motley Fool
- Buy Plus500 Ltd (DI) (PLUS) by Jon Smith in The Motley Fool
- Watch Halma (HLMA) by Jabran Khan in The Motley Fool
- Buy Just Eat Takeaway.Com N.V. (CDI) (JET) by Manika Premsingh in The Motley Fool
Oxford Biomedica (OXB)
Health Care Sector
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Stock Splits and Consolidations
30/05/2018 – Stock Consolidation 50.000:1.000
Oxford Biomedica Overview
Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.Latest Oxford Biomedica Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Alan Oscroft | – | 2021-10-26 14:05:00 26/10/2021 | – |
| – | Peel Hunt | – | 2021-10-19 16:46:00 19/10/2021 | – |
| – | Liberum Capital | – | 2021-09-30 07:41:00 30/09/2021 | – |
| – | Jefferies | – | 2021-09-28 04:47:00 28/09/2021 | – |
| – | Emma Powell | – | 2021-09-23 07:35:00 23/09/2021 | – |
| Latest Bid : – | Latest Ask : – |
| High Today : – | Low Today : – |
| This Years High : – | This Years Low : – |
| Volume : – | MKT Cap : – |
Oxford Biomedica Overview
Oxford Biomedica develops innovative new IP-protected , LentiVector® based therapies, leveraging our internal research expertise and know-how. We select patient-centric product candidates and progress these through proof-of-concept, and into early clinical development, before either seeking third-party funding for full development and commercialisation or to develop further in-house.Latest Oxford Biomedica Tips
| Type | Tipster | SectorScore | Start date | Performance |
|---|---|---|---|---|
| – | Alan Oscroft | – | 2021-10-26 14:05:00 26/10/2021 | – |
| – | Peel Hunt | – | 2021-10-19 16:46:00 19/10/2021 | – |
| – | Liberum Capital | – | 2021-09-30 07:41:00 30/09/2021 | – |
| – | Jefferies | – | 2021-09-28 04:47:00 28/09/2021 | – |
| – | Emma Powell | – | 2021-09-23 07:35:00 23/09/2021 | – |
Stock Splits and Consolidations
30/05/2018 – Stock Consolidation 50.000:1.000